Aarkstore.com announces, The Latest market research report is available inits vast collection:Acorda Therapeutics, Inc. – Product Pipeline Review – 2012http://www.aarkstore.com/reports/Acorda-Therapeutics-Inc-Product-Pipeline-Review-2012-217860.htmlSummaryGlobal Market Direct’s pharmaceuticals report, “Acorda Therapeutics, Inc. - ProductPipeline Review - 2012” provides data on the Acorda Therapeutics, Inc.’s researchand development focus. The report includes information on current developmentalpipeline, complete with latest updates, and features on discontinued and dormantprojects.This report is built using data and information sourced from Global Markets Direct’sproprietary databases, Acorda Therapeutics, Inc.’s corporate website, SEC filings,investor presentations and featured press releases, both from Acorda Therapeutics,Inc. and industry-specific third party sources, put together by Global MarketsDirect’s team.Scope- Acorda Therapeutics, Inc. - Brief Acorda Therapeutics, Inc. overview includingbusiness description, key information and facts, and its locations and subsidiaries.- Review of current pipeline of Acorda Therapeutics, Inc. human therapeuticdivision.- Overview of pipeline therapeutics across various therapy areas.- Coverage of current pipeline molecules in various stages of drug development,including the combination treatment modalities, across the globe.
Table of contents:List of Tables 5List of Figures 5Acorda Therapeutics, Inc. Snapshot 6Acorda Therapeutics, Inc. Overview 6Key Information 6Key Facts 6Acorda Therapeutics, Inc. – Research and Development Overview 7Key Therapeutic Areas 7Acorda Therapeutics, Inc. – Pipeline Review 9Pipeline Products by Stage of Development 9Pipeline Products – Monotherapy 10Acorda Therapeutics, Inc. – Pipeline Products Glance 11Acorda Therapeutics, Inc. Clinical Stage Pipeline Products 11Phase II Products/Combination Treatment Modalities 11Phase I Products/Combination Treatment Modalities 12Acorda Therapeutics, Inc. – Early Stage Pipeline Products 13Pre-Clinical Products/Combination Treatment Modalities 13Acorda Therapeutics, Inc. – Drug Profiles 14AC105 14Product Description 14Mechanism of Action 14R&D Progress 14Chondroitinase Program 15Product Description 15Mechanism of Action 15R&D Progress 15GGF2 17Product Description 17Mechanism of Action 17R&D Progress 17rHIgM22 19Product Description 19Mechanism of Action 19R&D Progress 19
List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Product Pipeline Review – 2012http://www.aarkstore.com/search/viewresults.asp?search=Product PipelineReview&PubId=&pagenum=1Acacia Pharma Ltd. – Product Pipeline Review – 2012Acceleron Pharma, Inc. – Product Pipeline Review – 2012Access Pharmaceuticals, Inc. – Product Pipeline Review – 2012Achaogen Inc. – Product Pipeline Review – 2012Acorda Therapeutics, Inc. – Product Pipeline Review – 2012Glycotope GmbH – Product Pipeline Review – 2012Aquinox Pharmaceuticals Inc. – Product Pipeline Review – 2012Avaxia Biologics, Inc. – Product Pipeline Review – 2012Bharat Biotech International Limited – Product Pipeline Review – 2012Bio3 Research S.r.l – Product Pipeline Review – 2012Cardax Pharmaceuticals, Inc. – Product Pipeline Review – 2012Cellceutix Pharmaceuticals, Inc. – Product Pipeline Review – 2012Curacyte AG – Product Pipeline Review – 2012
Fresenius Biotech GmbH – Product Pipeline Review – 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcarehttp://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals andHealthcare&PubId=&pagenum=1You can also request for sample page of above mention reports firstname.lastname@example.orgFor More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: email@example.com